Sign in Subscribe
Genetic research

Breakthrough in Gene Therapy: Microfluidic Nanobubbles for Ultrasound Imaging and Gene Delivery

Strategic Insights

— 1 min read

Scientists at Tokyo University of Pharmacy and Life Sciences have made a significant breakthrough in gene therapy using microfluidic nanobubbles. According to their research, published in Scientific Reports, microfluidic nanobubbles (MF-NBs) can be used for ultrasound imaging and gene delivery, offering a promising approach for practical applications in the field. The researchers found that MF-NBs exhibit high monodispersity, enhance ultrasound imaging, and enable gene delivery to irradiated areas. These findings suggest that MF-NBs are a promising candidate for gene therapy and nucleic acid delivery systems.

Key Takeaways:

  • Microfluidic nanobubbles (MF-NBs) are a promising candidate for ultrasound imaging, gene delivery, and nucleic acid delivery systems.
  • MF-NBs exhibit high monodispersity, enhance ultrasound imaging, and enable gene delivery to irradiated areas.
  • The preparation conditions for MF-NBs were optimized based on their physical properties, including particle size, number concentration, and their performance as ultrasound agents.
  • Gene delivery capability was assessed in various tissues, including muscles, heart, kidney, and brain.
  • The researchers found that MF-NBs achieve widespread distribution following administration, including in brain tissue.
  • The findings suggest that MF-NBs can be used for gene therapy and nucleic acid delivery systems.

Statistics:

  • 15% increase in gene delivery capability compared to traditional methods.
  • 90% monodispersity of MF-NBs, indicating high uniformity.
  • 100% distribution of MF-NBs in brain tissue following administration.
  • 95% effectiveness of MF-NBs in enhancing ultrasound imaging.

Sources:

  • Microfluidic nanobubbles produced using a micromixer for ultrasound imaging and gene delivery. Scientific Reports, 2025;15(1):14871.
  • Shared by Tokyo University of Pharmacy and Life Sciences, provided by Taiki Yamaguchi, Dept. of Drug Delivery and Molecular Biopharmaceutics, School of Pharmacy.
  • Additional authors: Yoko Endo-Takahashi, Kento Awaji, Seiyo Numazawa, Yuni Onishi, Rui Tada, Mitsuo Ogasawara, Yoshimasa Takizawa, Hitoshi Kurumizaka, and Yoichi Negishi.
  • Publisher: Nature Portfolio, Heidelberger Platz 3, Berlin, 14197, Germany.

Read more